Oncology Venture - to participate and present at the Annual BioEurope Conference
Hoersholm, Denmark – November 3rd 2017 – Oncology Venture Sweden AB (OV:ST) announces that OV will participate and present at the 23rd Annual International Bio-Europe Partnering Conference, on November 6-8, in Berlin.Chief Executive Officer, MD, PhD Peter Buhl Jensen, will present Oncology Venture at Bio-Europe, November 7th 2017 at 5:30pm CET, with a discussion period to follow. Furthermore, Peter Buhl Jensen will hold 1x1 meetings, joined by Chief Operating Officer, Ulla Hald Buhl, and Vice President, Business Development, Claus Deichgræber. Over 30 meetings are now scheduled.